These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10843204)

  • 1. Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.
    Weber KT; Hammache D; Fantini J; Ganem B
    Bioorg Med Chem Lett; 2000 May; 10(10):1011-4. PubMed ID: 10843204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiphilic anionic analogues of galactosylceramide: synthesis, anti-HIV-1 activity, and gp120 binding.
    Faroux-Corlay B; Greiner J; Terreux R; Cabrol-Bass D; Aubertin AM; Vierling P; Fantini J
    J Med Chem; 2001 Jun; 44(13):2188-203. PubMed ID: 11405656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.
    Augustin LA; Fantini J; Mootoo DR
    Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic neoglycolipids for biological applications: correlation between their structures and their interactions with membrane proteins.
    Rico-Lattes I; Gouzy MF; Andre-Barres C; Guidetti B; Lattes A
    Biochimie; 1998; 80(5-6):483-7. PubMed ID: 9782388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.
    Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F
    Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel glycolipids that bind HIV-1 Gp120.
    LaBell RY; Jacobsen NE; Gervay-Hague J; O'Brien DF
    Bioconjug Chem; 2002; 13(1):143-9. PubMed ID: 11792190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the interaction between the gp120 and the HIV receptor in human sperm (human.sperm/gp120/galactoglycerolipid/antigalactosylceramide/seminolip id/spermatogonia).
    Brogi A; Presentini R; Moretti E; Strazza M; Piomboni P; Costantino-Ceccarini E
    J Reprod Immunol; 1998 Dec; 41(1-2):213-31. PubMed ID: 10213312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 receptor: new tools to study virus-glycolipid interactions.
    Villard R; Hammache D; Delapierre G; Fotiadu F; Buono G; Fantini J
    Chembiochem; 2002 Jun; 3(6):517-25. PubMed ID: 12325007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm.
    Brogi A; Presentini R; Solazzo D; Piomboni P; Costantino-Ceccarini E
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):483-9. PubMed ID: 8679303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.
    Long D; Berson JF; Cook DG; Doms RW
    J Virol; 1994 Sep; 68(9):5890-8. PubMed ID: 8057468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.
    Fantini J; Cook DG; Nathanson N; Spitalnik SL; Gonzalez-Scarano F
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2700-4. PubMed ID: 8464878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.
    Bhat S; Spitalnik SL; Gonzalez-Scarano F; Silberberg DH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7131-4. PubMed ID: 1871126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of HIV-1 gp120 glycoprotein binding to glycolipids.
    McAlarney T; Apostolski S; Lederman S; Latov N
    J Neurosci Res; 1994 Mar; 37(4):453-60. PubMed ID: 8021969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurements of recombinant HIV surface glycoprotein 120 binding to several glycosphingolipids expressed in planar supported lipid bilayers.
    Conboy JC; McReynolds KD; Gervay-Hague J; Saavedra SS
    J Am Chem Soc; 2002 Feb; 124(6):968-77. PubMed ID: 11829604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides.
    Bachan S; Fantini J; Joshi A; Garg H; Mootoo DR
    Bioorg Med Chem; 2011 Aug; 19(16):4803-11. PubMed ID: 21783371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human sperm and spermatogonia express a galactoglycerolipid which interacts with gp120.
    Brogi A; Presentini R; Piomboni P; Collodel G; Strazza M; Solazzo D; Costantino-Ceccarini E
    J Submicrosc Cytol Pathol; 1995 Oct; 27(4):565-71. PubMed ID: 7585449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs.
    Ratner L; Vander Heyden N
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):291-7. PubMed ID: 8390276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of biotinylated glycoconjugates and their use in a novel ELISA for direct comparison of HIV-1 Gp120 recognition of GalCer and related carbohydrate analogues.
    McReynolds KD; Hadd MJ; Gervay-Hague J
    Bioconjug Chem; 1999; 10(6):1021-31. PubMed ID: 10563771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins.
    Shimizu H; Tsuchie H; Honma H; Yoshida K; Tsuruoka T; Ushijima H; Kitamura T
    Jpn J Med Sci Biol; 1990 Jun; 43(3):75-87. PubMed ID: 2283726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.